Stocks › BBTX
Bambusa Therapeutics, Inc.
BBTX·Nasdaq·
United States·USD
$16.00
+0.45 (+2.89%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
BBTX
Bambusa Therapeutics, Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
BBTXS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of BBTX by members of U.S. Congress · 0 on record
No congressional trades in BBTX on record.
Whale Activity
Institutional 13F positions
No 13F filer has reported a position in BBTX for a completed quarter.
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Net shares bought (+) or sold (−) on the open market by BBTX insiders, by quarter · Form 4
Recent Insider Transactions
6 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. / RA Capital Healthcare Fund LP / RA Capital Nexus Fund III, L.P. / Kolchinsky Peter / Shah Rajeev M.Director · Director | Purchase | +2.3M | n/c | — | Nov 2, 2026 | Form 4 ↗ |
| RA CAPITAL MANAGEMENT, L.P. / RA Capital Healthcare Fund LP / RA Capital Nexus Fund III, L.P. / Kolchinsky Peter / Shah Rajeev M.Director · Director | Purchase | +164.9K | $16.00 | $2.6M | Nov 2, 2026 | Form 4 ↗ |
| Salvia Investment GmbH | Purchase | +375.0K | $16.00 | $6.0M | Nov 2, 2026 | Form 4 ↗ |
| RA CAPITAL MANAGEMENT, L.P. / RA Capital Healthcare Fund LP / RA Capital Nexus Fund III, L.P. / Kolchinsky Peter / Shah Rajeev M.Director · Director | Purchase | +263.9K | $14.92 | $3.9M | Oct 30, 2026 | Form 4 ↗ |
| RA CAPITAL MANAGEMENT, L.P. / RA Capital Healthcare Fund LP / RA Capital Nexus Fund III, L.P. / Kolchinsky Peter / Shah Rajeev M.Director · Director | Purchase | +189.9K | $14.23 | $2.7M | Oct 30, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding BBTX · SEC Form N-PORT
Funds report their holdings by CUSIP, and BBTX could not be matched to one, so no fund holdings are shown.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- RA Capital Healthcare Fund, L.P.SCHEDULE 13D · activist (13D) · 5.9M shares11.6%
Nov 6, 2026 · ↗ - Rajeev ShahSCHEDULE 13D · activist (13D) · 7.4M shares14.6%
Nov 6, 2026 · ↗ - Peter KolchinskySCHEDULE 13D · activist (13D) · 7.4M shares14.6%
Nov 6, 2026 · ↗ - RA Capital Management, L.P.SCHEDULE 13D · activist (13D) · 7.4M shares14.6%
Nov 6, 2026 · ↗ - Thomas MaierSCHEDULE 13G · passive (13G) · 4.7M shares9.2%
Nov 5, 2026 · ↗ - Salzufer Holding Inc.SCHEDULE 13G · passive (13G) · 4.6M shares9.0%
Nov 5, 2026 · ↗ - Objektgesellschaft Salzufer 1 GmbHSCHEDULE 13G · passive (13G) · 4.6M shares9.0%
Nov 5, 2026 · ↗ - ATHOS KGSCHEDULE 13G · passive (13G) · 4.6M shares9.0%
Nov 5, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming Bambusa Therapeutics, Inc. as client
No lobbying filings found naming Bambusa Therapeutics, Inc. as the client.
Government Contracts
Federal awards to Bambusa Therapeutics, Inc. · USAspending
No federal contract awards found for Bambusa Therapeutics, Inc..
U.S. Patents
Recent USPTO applications naming Bambusa Therapeutics, Inc.
No USPTO patent applications found for Bambusa Therapeutics, Inc..
Annual Financials
From BBTX's 10-K filings · XBRL
SEC holds no annual XBRL figures in US dollars for Bambusa Therapeutics, Inc..
Stock Splits
Every split and reverse split in the price history
No stock splits in BBTX's price history.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 5.03, 7.01, 9.01Bylaw amendment · Reg FD disclosureNov 3, 2026
EDGAR ↗
About Bambusa Therapeutics, Inc.
From SEC EDGAR company records
Industry (SIC 2836)Biological Products, (No Diagnostic Substances)
SectorHealthcare
HeadquartersBOSTON, MA
IncorporatedDE
SEC CIK0002044950 ↗
